Jiangxi Fushine Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300497.SZ

Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD -9.12 M

Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow is USD -9.12 M for the year ending December 31, 2023, a 47.91% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD -17.51 M, a -253.86% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 11.38 M, a -80.57% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 58.58 M, a 20.72% change year over year.
  • Jiangxi Fushine Pharmaceutical Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 48.52 M, a 89.71% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
SV Wall Street
Shenzhen Stock Exchange: 300497.SZ

Jiangxi Fushine Pharmaceutical Co., Ltd.

CEO Mr. Jian Hua Bao
IPO Date Dec. 22, 2015
Location China
Headquarters No. 2, Yuli Industrial Zone
Employees 1,963
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.

StockViz Staff

January 31, 2025

Any question? Send us an email